ACM
GRTS

ACT Capital Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

ACT Capital Management’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$122K Hold
47,500
– – 0.17% 48
2022
Q2 		$115K Hold
47,500
– – 0.16% 47
2022
Q1 		$196K Buy
47,500
+7,500
+19% +$39.7K 0.21% 49
2021
Q4 		$514K Sell
40,000
-34,000
-46% -$376K 0.37% 46
2021
Q3 		$799K Buy
+74,000
New +$673K 0.41% 43

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

ACT Capital Management's GRTS Position: Q3 2022 in Review

ACT Capital Management held its Gritstone bio, Inc. Common Stock (GRTS) position steady in Q3 2022 at 47,500 shares worth $122K. The position accounts for 0.17% of the portfolio, ranked #48.

ACT Capital Management first reported a position in GRTS in Q3 2021 and has held it in 5 quarters since. The position peaked at $799K in Q3 2021. 79 funds tracked by Wall St. Rank hold GRTS as of Q3 2022.

  • ACT Capital Management held 47,500 shares of Gritstone bio, Inc. Common Stock worth $122K as of Q3 2022.
  • ACT Capital Management left its Gritstone bio, Inc. Common Stock share count unchanged in Q3 2022.
  • Gritstone bio, Inc. Common Stock made up 0.17% of ACT Capital Management's portfolio in Q3 2022, its #48 holding.
  • ACT Capital Management first reported a position in Gritstone bio, Inc. Common Stock in Q3 2021 and has held it in 5 quarters since.
  • ACT Capital Management's Gritstone bio, Inc. Common Stock position peaked at $799K in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2022.

Based on ACT Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.